<document xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:z="http://www.ebi.ac.uk/z" source="Whatizit"><text><SENT sid="0" pm="."><plain>AIM: <z:chebi fb="0" ids="17620">Ferulic acid</z:chebi> (4-hydroxy-3-methoxycinnamic acid, FA) provides neuroprotection against <z:mpath ids='MPATH_3'>apoptosis</z:mpath> in a transient middle cerebral <z:mp ids='MP_0006134'>artery occlusion</z:mp> (MCAo) model </plain></SENT>
<SENT sid="1" pm="."><plain>This study was to further investigate the anti-apoptotic effect of FA during reperfusion after <z:hpo ids='HP_0002637'>cerebral ischemia</z:hpo> </plain></SENT>
<SENT sid="2" pm="."><plain>METHODS: Rats were subjected to 90 min of <z:hpo ids='HP_0002637'>cerebral ischemia</z:hpo> followed by 3 or 24 h of reperfusion after which they were sacrificed </plain></SENT>
<SENT sid="3" pm="."><plain>RESULTS: Intravenous FA (100 mg/kg) administered immediately after middle cerebral <z:mp ids='MP_0006134'>artery occlusion</z:mp> (MCAo) or 2 h after reperfusion effectively abrogated the elevation of postsynaptic density-95 (PSD-95), neuronal nitric <z:chebi fb="177" ids="25741,29356">oxide</z:chebi> synthase (nNOS), inducible nitric <z:chebi fb="177" ids="25741,29356">oxide</z:chebi> synthase (iNOS), nitrotyrosine, and cleaved caspase-3 levels as well as <z:mpath ids='MPATH_3'>apoptosis</z:mpath> in the ischemic cortex at 24 h of reperfusion </plain></SENT>
<SENT sid="4" pm="."><plain>FA further inhibited Bax translocation, <z:chebi fb="1" ids="18070">cytochrome c</z:chebi> release, and p38 <z:chebi fb="0" ids="52290">mitogen</z:chebi>-activated protein (MAP) kinase phosphorylation </plain></SENT>
<SENT sid="5" pm="."><plain>Moreover, FA enhanced the expression of <z:chebi fb="0" ids="16865">gamma-aminobutyric acid</z:chebi> type B receptor subunit 1 (<z:chebi fb="3" ids="16865">GABA</z:chebi>(B1)) in the ischemic cortex at 3 and 24 h of reperfusion </plain></SENT>
<SENT sid="6" pm="."><plain>In addition, nitrotyrosine-positive cells colocalized with cleaved caspase-3-positive cells, and phospho-p38 MAP kinase-positive cells colocalized with nitrotyrosine- and Bax-positive cells, indicating a positive relationship among the expression of nitrotyrosine, phospho-p38 MAP kinase, Bax, and cleaved caspase-3 </plain></SENT>
<SENT sid="7" pm="."><plain>The mutually exclusive expression of <z:chebi fb="3" ids="16865">GABA</z:chebi>(B1) and nitrotyrosine revealed that there is a negative correlation between <z:chebi fb="3" ids="16865">GABA</z:chebi>(B1) and nitrotyrosine expression profiles </plain></SENT>
<SENT sid="8" pm="."><plain>Additionally, pretreatment with saclofen, a <z:chebi fb="3" ids="16865">GABA</z:chebi>(B) receptor <z:chebi fb="68" ids="48706">antagonist</z:chebi>, abolished the neuroprotection of FA against nitric <z:chebi fb="177" ids="25741,29356">oxide</z:chebi> (NO)-induced <z:mpath ids='MPATH_3'>apoptosis</z:mpath> </plain></SENT>
<SENT sid="9" pm="."><plain>CONCLUSION: FA significantly enhances <z:chebi fb="3" ids="16865">GABA</z:chebi>(B1) receptor expression at early reperfusion and thereby provides neuroprotection against p38 MAP kinase-mediated NO-induced <z:mpath ids='MPATH_3'>apoptosis</z:mpath> at 24 h of reperfusion </plain></SENT>
</text></document>